Brain-imaging studies of treatment-resistant schizophrenia: a systematic review
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background Approximately 30% of patients with schizophrenia show an inadequate response to antipsychotics, termed treatment resistance. Neuroimaging studies may help elucidate the underlying neurobiological reasons that certain patients show inadequate treatment response, and help identify them earlier. In addition, studies examining the effect of clozapine on the brain may help identify which aspects of clozapine make it uniquely effective in treatment resistance. Method We performed a systematic search of PubMed between January 1980 and April 2015 in order to identify all neuroimaging studies that had examined treatment resistant patients, or longitudinally studied the effects of clozapine treatment. Findings The search identified 330 papers, of which 60 met inclusion criteria. Replicated differences in treatment resistant relative to responsive patients include reductions in gray matter and perfusion of frontotemporal regions and increases in white matter and basal ganglia perfusion. Clozapine treatment has been shown to lead to reductions in caudate nuclei volumes in three separate studies. Interpretation The available evidence supports the possibility that some of the neurobiological changes observed in resistant schizophrenia lie along a continuum with non resistant schizophrenia; while other differences may be more categorical in nature. There is, however, limited replication and in order for neuroimaging findings to be clinically translatable, future studies need to provide clear a priori hypotheses and test these rigorously. Funding This study was funded by Medical Research Council-UK (no. MC-A656-5QD30), Maudsley Charity (no. 666) and Wellcome Trust (no. 094849/Z/10/Z) grants to Dr Howes and the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. Contributors OH and EM conceived of the study and designed the literature search. RM and EM reviewed abstracts, selected studies for inclusion and extracted data. EM, RM and OH wrote the manuscript.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Self-citationThe social and economic burden of treatment-resistant schizophrenia: a systematic literature review
Kennedy, J. L., Altar, C. A., Taylor, D. L., Degtiar, I., & Hornberger, J. C. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32836508e6 · Cited by 392
Stone, J. M., Dietrich, C., Edden, R., Mehta, M. A., De Simoni, S., Reed, L. J., Krystal, J. H., Nutt, D., & Barker, G. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.171 · Cited by 295
Samaha, A.-N., Seeman, P., Stewart, J., Rajabi, H., & Kapur, S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5416-06.2007 · Cited by 262
Vercammen, A., Knegtering, H., den Boer, J. A., Liemburg, E. J., & Aleman, A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.017 · Cited by 261 · cited 1×
“Vercammen et al. 2010 rsMRI ↓ FC in TR-AVH between the Left TPJ and Right IFG.”
Fusar-Poli, P., Howes, O. D., Allen, P., Broome, M., Valli, I., Asselin, M.-C., Montgomery, A. J., Grasby, P. M., & McGuire, P. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.108 · Cited by 207
Self-citationHowes, O. D., & Kapur, S. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.138578 · Cited by 203
Self-citationThe natural history and pathophysiology of treatment resistant schizophrenia
Sheitman, B. B., & Lieberman, J. A. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00052-6 · Cited by 140
Lee, S.-H., Wynn, J. K., Green, M. F., Kim, H., Lee, K.-J., Nam, M., Park, J.-K., & Chung, Y.-C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.11.025 · Cited by 89 · cited 1×
“3.31(TR vs R) 4.00 (TR vs CNR) Demjaha et al. 2014 1H-MRS ↑ anterior cingulate glutamate in TR compared to R 0.70 (ns) Lee et al. 2006 EEG ↑ Beta1 in TR 0.61 ↑ Beta2 in TR 0.69 gamma-beta2 and beta3 correlation in TRS but not RS in posterior and anterior electrodes range of r=0.42-0.61 Lee et al.…”
InfluentialEgerton, A., Fusar-Poli, P., & M. Stone, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799316244 · Cited by 36
Cited by
McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3360 · Cited by 1,481
Self-citationDopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612
Self-citationPotkin, S. G., Kane, J. M., Correll, C. U., Lindenmayer, J.-P., Agid, O., Marder, S. R., Olfson, M., & Howes, O. D. (2020) · npj Schizophrenia · doi:10.1038/s41537-019-0090-z · Cited by 359
Self-citationGuidelines for the Pharmacotherapy of Schizophrenia in Adults
Remington, G., Addington, D., Honer, W., Ismail, Z., Raedler, T., & Teehan, M. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717720448 · Cited by 332
“The neurobiology of TRS shares some features with treatmentresponsive forms of the illness and has other distinct features.(79) Defining antipsychotic treatment requires a strategy for assessing patient symptoms and assessing the adequacy of treatment.”
BackgroundHeterogeneity and Homogeneity of Regional Brain Structure in Schizophrenia: A Meta-analysis
Brugger, S. P., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2663 · Cited by 332
Self-citation
Metadata
- Authors
- Mouchlianitis, E., McCutcheon, R., & Howes, O. D.
- Venue
- The Lancet Psychiatry
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 3
- Issue
- 5
- Pages
- 451-463
- ISSN
- 2215-0366 (ISSN-L)
- OpenAlex
- W2290746927
- Cited by
- 142
- References
- 16
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.